Latest Insider Transactions at Anaptysbio, Inc (ANAB)
This section provides a real-time view of insider transactions for Anaptysbio, Inc (ANAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ANAPTYSBIO, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ANAPTYSBIO, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2025
|
J. Anthony Ware |
SELL
Open market or private sale
|
Direct |
3,900
-28.82%
|
$191,100
$49.58 P/Share
|
|
Dec 23
2025
|
John P. Schmid |
SELL
Other acquisition or disposition
|
Indirect |
11,068
-100.0%
|
$564,468
$51.0 P/Share
|
|
Dec 22
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-52.78%
|
$510,000
$51.0 P/Share
|
|
Dec 22
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.55%
|
$140,000
$14.02 P/Share
|
|
Dec 22
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-51.54%
|
$500,000
$50.0 P/Share
|
|
Dec 22
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.01%
|
$200,000
$20.16 P/Share
|
|
Dec 22
2025
|
Paul F. Lizzul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,500
-5.27%
|
$75,000
$50.0 P/Share
|
|
Dec 22
2025
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.01%
|
$27,000
$18.5 P/Share
|
|
Dec 18
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
141
-1.55%
|
$6,486
$46.99 P/Share
|
|
Dec 17
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-52.39%
|
$460,000
$46.0 P/Share
|
|
Dec 17
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.38%
|
$140,000
$14.02 P/Share
|
|
Dec 16
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,725
-38.81%
|
$691,900
$44.91 P/Share
|
|
Dec 16
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.47%
|
$200,000
$20.16 P/Share
|
|
Dec 16
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-35.03%
|
$550,000
$44.96 P/Share
|
|
Dec 16
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+25.99%
|
$212,500
$17.09 P/Share
|
|
Sep 30
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,240
-47.55%
|
$238,960
$29.0 P/Share
|
|
Sep 30
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+22.39%
|
$70,000
$14.02 P/Share
|
|
Sep 15
2025
|
John A Orwin |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+10.87%
|
-
|
|
Aug 08
2025
|
Hollings Renton |
SELL
Open market or private sale
|
Direct |
10,231
-39.69%
|
$194,389
$19.57 P/Share
|
|
Aug 08
2025
|
Hollings Renton |
BUY
Exercise of conversion of derivative security
|
Direct |
10,231
+40.24%
|
$61,386
$6.93 P/Share
|
|
Jul 02
2025
|
Hollings Renton |
SELL
Open market or private sale
|
Direct |
20,925
-50.68%
|
$481,275
$23.46 P/Share
|
|
Jul 02
2025
|
Hollings Renton |
BUY
Exercise of conversion of derivative security
|
Direct |
20,925
+44.7%
|
$125,550
$6.93 P/Share
|
|
Jun 18
2025
|
Hollings Renton |
SELL
Open market or private sale
|
Direct |
3,015
-37.78%
|
$69,345
$23.97 P/Share
|
|
Jun 18
2025
|
Dennis M Fenton |
SELL
Open market or private sale
|
Direct |
3,015
-37.78%
|
$69,345
$23.97 P/Share
|
|
Jun 15
2025
|
John P. Schmid |
BUY
Exercise of conversion of derivative security
|
Direct |
6,030
+10.34%
|
-
|
|
Jun 15
2025
|
Hollings Renton |
BUY
Exercise of conversion of derivative security
|
Direct |
6,030
+43.04%
|
-
|
|
Jun 15
2025
|
John A Orwin |
BUY
Exercise of conversion of derivative security
|
Direct |
6,030
+39.17%
|
-
|
|
Jun 15
2025
|
Magda Marquet |
BUY
Exercise of conversion of derivative security
|
Direct |
6,030
+37.78%
|
-
|
|
Jun 15
2025
|
Dennis M Fenton |
BUY
Exercise of conversion of derivative security
|
Direct |
6,030
+43.04%
|
-
|
|
Jun 15
2025
|
Rita Jain |
BUY
Exercise of conversion of derivative security
|
Direct |
7,330
+38.19%
|
-
|
|
Jun 15
2025
|
J. Anthony Ware |
BUY
Exercise of conversion of derivative security
|
Direct |
6,030
+30.83%
|
-
|
|
Mar 25
2025
|
John P. Schmid |
BUY
Other acquisition or disposition
|
Indirect |
11,068
+50.0%
|
$199,224
$18.18 P/Share
|
|
Jan 13
2025
|
John P. Schmid |
BUY
Exercise of conversion of derivative security
|
Direct |
42,337
+38.37%
|
$254,022
$6.55 P/Share
|
|
Jan 06
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,217
-16.77%
|
$33,255
$15.3 P/Share
|
|
Jan 06
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,545
+29.55%
|
-
|
|
Jan 06
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,054
-12.95%
|
$30,810
$15.3 P/Share
|
|
Jan 06
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,245
+24.86%
|
-
|
|
Jan 06
2025
|
Paul F. Lizzul Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,261
-8.1%
|
$33,915
$15.3 P/Share
|
|
Jan 06
2025
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,145
+18.05%
|
-
|
|
Jan 06
2025
|
Daniel Faga President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,387
-1.44%
|
$95,805
$15.3 P/Share
|
|
Jan 06
2025
|
Daniel Faga President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,850
+3.87%
|
-
|
|
Jan 03
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,994
-28.06%
|
$41,916
$14.6 P/Share
|
|
Jan 03
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,288
+40.59%
|
-
|
|
Jan 03
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,407
-24.3%
|
$47,698
$14.6 P/Share
|
|
Jan 03
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,293
+37.17%
|
-
|
|
Jan 03
2025
|
Paul F. Lizzul Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,336
-16.62%
|
$60,704
$14.6 P/Share
|
|
Jan 03
2025
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,555
+28.8%
|
-
|
|
Jan 03
2025
|
Daniel Faga President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,033
-2.98%
|
$182,462
$14.6 P/Share
|
|
Jan 03
2025
|
Daniel Faga President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,678
+7.34%
|
-
|
|
Jan 02
2025
|
Eco R1 Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
6,646
+0.08%
|
$79,752
$12.95 P/Share
|